BBS4 directly affects proliferation and differentiation of adipocytes

Olga Aksanov, Pnina Green, Ruth Z. Birk

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


BBS4 is one of several proteins whose defects cause Bardet-Biedl syndrome (BBS), a multi-systemic disorder, manifesting with marked obesity. BBS4 polymorphisms have been associated with common non-syndromic morbid obesity. BBS4 obesity molecular mechanisms, and the role of the BBS4 gene in adipocyte differentiation and function are not entirely known. We now show that Bbs4 plays a direct and essential role in proliferation and adipogenesis: silencing of Bbs4 in 3T3F442A preadipocytes induced accelerated cell division and aberrant differentiation, evident through morphologic studies (light, scanning and transmission electron microscopy), metabolic analyses (fat accumulation, fatty acid profile and lipolysis) and adipogenic markers transcripts (Cebpα, Pparγ, aP2, ADRP, Perilipin). Throughout adipogenesis and when challenged with fat load, Bbs4 silenced cells accumulate significantly more triglycerides than control adipocytes, albeit in smaller (yet greater in number) droplets containing modified fatty acid profiles. Thus, greater fat accumulation in the silenced cells is a consequence of both a higher rate of adipocyte proliferation and of aberrant differentiation leading to augmented aberrant accumulation of fat per cell. Our findings suggest that the BBS obesity might be partly due to a direct role of BBS4 in physiological and pathophysiological mechanisms that underlie adipose tissue formation relevant to obesity.

Original languageEnglish
Pages (from-to)3381-3392
Number of pages12
JournalCellular and Molecular Life Sciences
Issue number17
StatePublished - Sep 2014


  • Adipogenesis
  • Bardet-Biedl syndrome (BBS)
  • Obesity


Dive into the research topics of 'BBS4 directly affects proliferation and differentiation of adipocytes'. Together they form a unique fingerprint.

Cite this